← Back to Search

Minimally Invasive Right Hemicolectomy for Colorectal Disorders (RICART Trial)

N/A
Recruiting
Led By James W Ogilvie, Jr., MS
Research Sponsored by Spectrum Health Hospitals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Eligible patients are those over 18 years of age who are regularly scheduled to undergo a right hemicolectomy via a minimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis. Right colectomy will be defined as removal of the ascending colon, ligation of the ileocolic artery and vein, +/- removal of the terminal ileum, +/- removal of the proximal transverse colon, and +/- removal of the right branch of the middle colic artery and vein.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 weeks
Awards & highlights

RICART Trial Summary

This trial is for adult patients who need a right hemicolectomy, which is a surgery to remove part of the large intestine. The surgery will be done using a minimally invasive approach, which means either through tiny incisions with a robotic arm or through a laparoscope. The anastomosis is where the two ends of the intestine are reconnected.

Who is the study for?
This trial is for adults over 18 who need a right hemicolectomy, which is surgery to remove part of the colon, using minimally invasive methods. It's not for prisoners, those unable to consent, emergency cases, pregnant women or if additional colon resection like left colectomy is planned.Check my eligibility
What is being tested?
The study tests whether creating an anastomosis (connection between two parts of the intestine) inside the body after a right hemicolectomy leads to faster bowel function recovery and earlier hospital discharge compared to other methods.See study design
What are the potential side effects?
Potential side effects may include typical surgical risks such as infection, bleeding, pain at the incision site, and complications related to bowel function and healing at the anastomosis site.

RICART Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and scheduled for a specific minimally invasive colon surgery.

RICART Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Return of bowel function
Secondary outcome measures
Incision length
Inpatient length of stay
Operating room charges
+3 more

RICART Trial Design

2Treatment groups
Experimental Treatment
Group I: Intra-corporealExperimental Treatment1 Intervention
Right Hemicolectomy
Group II: Extra-corporealExperimental Treatment1 Intervention
Right Hemicolectomy

Find a Location

Who is running the clinical trial?

Spectrum Health HospitalsLead Sponsor
65 Previous Clinical Trials
553,178 Total Patients Enrolled
James W Ogilvie, Jr., MSPrincipal InvestigatorSpectrum Health Hospitals

Media Library

Intra-Corporeal Anastomosis Clinical Trial Eligibility Overview. Trial Name: NCT03862781 — N/A
Colorectal Disorders Research Study Groups: Intra-corporeal, Extra-corporeal
Colorectal Disorders Clinical Trial 2023: Intra-Corporeal Anastomosis Highlights & Side Effects. Trial Name: NCT03862781 — N/A
Intra-Corporeal Anastomosis 2023 Treatment Timeline for Medical Study. Trial Name: NCT03862781 — N/A
~26 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top